Monovisc
Monovisc is a synovial fluid supplementation medium (FDA Class III; FDA product code MOZ, Acid, Hyaluronic, Intraarticular) made by Ally Medical Supplies Ltd, approved under FDA PMA P090031 on 25 Feb 2014 and listed in FDA GUDID since 13 Sep 2016 (UDI-DI 05060459970090), active as of 22 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05060459970090 | Date13 Sep 2016 | StatusListed |
| United States | FDA PMAAPPR | NumberP090031 | Date25 Feb 2014 | StatusActive |
Official records
- AccessGUDID record 05060459970090
- FDA PMA database P090031
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA PMA P090031 decided 25 Feb 2014 Active
- FDA GUDID UDI-DI 05060459970090 listed 13 Sep 2016 Listed
Timeline
- Approved FDA PMA P090031
- Listed FDA GUDID 05060459970090
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic name
- Synovial fluid supplementation medium
- Primary DI / UDI-DI
- 05060459970090
- PMA number
- FDA product code
- MOZ
- GMDN term
- Synovial fluid supplementation medium
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- Monovisc Injectable Intra-Articular Device by Anika Therapeutics, Inc.
- SYNOJOYNT by Mesoblast
- TriVisc by Channel-Markers Medical, LLC
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.
- TRILURON by Fidia Farmaceutici S.p.A.
- Supartz by Seikagaku Corp.
- Gel-One by Seikagaku Corp.
- GenVisc 850 by Channel-Markers Medical, LLC
- Hymovis High Molecular Weight Viscoelastic Hyaluronan by Fidia Farmaceutici
- Orthovisc High Molecular Weight Hyaluronan by Anika Therapeutics, Inc.